Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-14-003900

CHIEF OPERATING OFFICER bought 10,000 shares at $0.94 ($9,400)

From the SEC's structured data for this filing

Trades in this filing

Rhonemus Troy Allen · CHIEF OPERATING OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-12-15 Purchase : show line 1 in the form +10,000 $0.94 $9,400 10,000 I
Open-market purchases · 10,000 sh · avg $0.94 · $9,400
Loading xslF345X03/form4-12162014_011226.xml…